A detailed history of Pictet Asset Management Holding Sa transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 2,409,954 shares of IONS stock, worth $98.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,409,954
Previous 3,739,757 35.56%
Holding current value
$98.4 Million
Previous $162 Million 29.15%
% of portfolio
0.13%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$36.45 - $47.7 $48.5 Million - $63.4 Million
-1,329,803 Reduced 35.56%
2,409,954 $115 Million
Q1 2024

May 14, 2024

BUY
$42.03 - $53.55 $9.31 Million - $11.9 Million
221,440 Added 6.29%
3,739,757 $162 Million
Q4 2023

Feb 13, 2024

BUY
$43.39 - $51.63 $12 Million - $14.3 Million
277,383 Added 8.56%
3,518,317 $178 Million
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $125 Million - $153 Million
3,240,934 New
3,240,934 $147 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.8B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.